Sfoglia per AUTORE
SORIO R
Collezione ASL Biella
Items : 2
MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATIN-PACLITAXELBEVACIZUMAB VS CARBOPLATIN-PACLITAXELBEVACIZUMAB- RUCAPARIB VS CARBOPLATINPACLITAXEL- RUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED OVARIAN CANCER in International Journal of Gynecological Cancer
2022
ASL Città di Torino
ASL Biella
ASL Città di Torino
ASL Biella
Musacchio L; Salutari V; Pignata S; Valabrega G; Zavallone L; Cormio G; Mosconi AM; Giolitto S; Camarda F; Ricci C; Zamagni C; Nero C; Carbone MV; Ghizzoni V; Sorio R; Salvatore S; Tronconi F; Savarese A; Scambia G; Lorusso D;
MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATINPACLITAXEL- BEVACIZUMAB VS CARBOPLATIN-PACLITAXEL-BEVACIZUMABRUCAPARIB VS CARBOPLATIN-PACLITAXELRUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED (STAGE III B-C-IV) OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER in International Journal of Gynecological Cancer
2022
ASL Città di Torino
ASL Biella
ASL Città di Torino
ASL Biella
Musacchio L; Salutari V; Pignata S; Valabrega G; Zavallone L; Cormio G; Mosconi AM; Giolitto S; Giudice E; Ricci C; Zamagni C; Nero C; Carbone MV; Ghizzoni V; Sorio R; Siena S; Tronconi F; Savarese A; Scambia G; Lorusso D;